These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
204 related items for PubMed ID: 6145099
21. A comparison of the effects of acute and one year's continuous neuroleptic treatment on the release of [3H]glutamate and [3H]acetylcholine from rat striatal slices. Kerwin RW, Rupniak NM, Jenner P, Marsden CD. Neuroscience; 1984 Jan; 11(1):205-10. PubMed ID: 6143281 [Abstract] [Full Text] [Related]
22. Clozapine blocks D-amphetamine-induced excitation of dopamine neurons in the ventral tegmental area. Shi WX, Zhang XY, Pun CL, Bunney BS. Neuropsychopharmacology; 2007 Sep; 32(9):1922-8. PubMed ID: 17299514 [Abstract] [Full Text] [Related]
23. Stereoisomers of the atypical neuroleptic carbidine modulate striatal dopamine release in awake rats. Guinetdinov RR, Bogdanov MB, Pogorelov VM, Kudrin VS, Rayevsky KS. Neuropharmacology; 1991 Nov; 30(11):1251-4. PubMed ID: 1685561 [Abstract] [Full Text] [Related]
24. Electrophysiological profile of the new atypical neuroleptic, sertindole, on midbrain dopamine neurones in rats: acute and repeated treatment. Skarsfeldt T. Synapse; 1992 Jan; 10(1):25-33. PubMed ID: 1346943 [Abstract] [Full Text] [Related]
25. Regionally specific effects of haloperidol and clozapine on dopamine reuptake in the striatum. Rothblat DS, Schneider JS. Neurosci Lett; 1997 Jun 06; 228(2):119-22. PubMed ID: 9209113 [Abstract] [Full Text] [Related]
26. Comparison of circling induced by unilateral intrastriatal microinjections of haloperidol, clozapine and CCK-8 in rats. Weiss F, Ettenberg A. Pharmacol Biochem Behav; 1986 Apr 06; 24(4):983-9. PubMed ID: 3012602 [Abstract] [Full Text] [Related]
27. Effects of amfonelic acid, alpha-methyltyrosine, Ro 4-1284 and haloperidol pretreatment on the depletion of striatal dopamine by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW, Hemrick-Luecke SK. Res Commun Chem Pathol Pharmacol; 1985 Apr 06; 48(1):17-25. PubMed ID: 3873102 [Abstract] [Full Text] [Related]
28. Utilization of microdialysis for assessing the release of mesotelencephalic dopamine following clozapine and other antipsychotic drugs. Moghaddam B, Bunney BS. Prog Neuropsychopharmacol Biol Psychiatry; 1990 Apr 06; 14 Suppl():S51-7. PubMed ID: 2097674 [Abstract] [Full Text] [Related]
29. Drug-induced rotation in rats without lesions: behavioral and neurochemical indices of a normal asymmetry in nigro-striatal function. Jerussi TP, Glick SD. Psychopharmacology (Berl); 1976 Jun 23; 47(3):249-60. PubMed ID: 823560 [Abstract] [Full Text] [Related]
31. Acute effects of typical and atypical antipsychotic drugs on the release of dopamine from prefrontal cortex, nucleus accumbens, and striatum of the rat: an in vivo microdialysis study. Moghaddam B, Bunney BS. J Neurochem; 1990 May 23; 54(5):1755-60. PubMed ID: 1969939 [Abstract] [Full Text] [Related]
32. Molecular and behavioral effects mediated by Gs-coupled adenosine A2a, but not serotonin 5-Ht4 or 5-Ht6 receptors following antipsychotic administration. Ward RP, Dorsa DM. Neuroscience; 1999 Mar 23; 89(3):927-38. PubMed ID: 10199625 [Abstract] [Full Text] [Related]
33. Influence of typical and atypical antipsychotics on neuropeptide Y-like immunoreactivity and NPY mRNA expression in rat striatum. Obuchowicz E, Turchan J. Neuropeptides; 1998 Oct 23; 32(5):473-80. PubMed ID: 9845010 [Abstract] [Full Text] [Related]
35. On the relevance of preferential increases of mesolimbic versus striatal dopamine turnover for the prediction of antipsychotic activity of psychotropic drugs. Waldmeier PC, Maître L. J Neurochem; 1976 Aug 23; 27(2):589-97. PubMed ID: 989496 [No Abstract] [Full Text] [Related]
37. Clozapine and haloperidol differentially alter the constitutive activity of central serotonin2C receptors in vivo. Navailles S, De Deurwaerdère P, Spampinato U. Biol Psychiatry; 2006 Mar 15; 59(6):568-75. PubMed ID: 16182256 [Abstract] [Full Text] [Related]
38. Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Walters JR, Roth RH. Naunyn Schmiedebergs Arch Pharmacol; 1976 Dec 15; 296(1):5-14. PubMed ID: 13315 [Abstract] [Full Text] [Related]
39. Blockade of both D1- and D2-dopamine receptors inhibits amphetamine-induced ascorbate release in the neostriatum. Oh C, Gardiner TW, Rebec GV. Brain Res; 1989 Feb 20; 480(1-2):184-9. PubMed ID: 2565749 [Abstract] [Full Text] [Related]
40. Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride. Prosser ES, Pruthi R, Csernansky JG. Psychopharmacology (Berl); 1989 Feb 20; 99(1):109-16. PubMed ID: 2506596 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]